Thymalin Research Overview (also known as Thymalin thymic extract, Khavinson thymus peptide, T-activin)
A peptide complex derived from the thymus gland studied for T-cell development support, immune calibration, and recovery from chronic inflammatory load. Research interest includes immune tone normalization and longevity applications. Often combined with Vilon and Crystagen in immune-focused research stacks.
What Is Thymalin?
Thymalin is a polypeptide preparation derived from bovine thymus gland through standardized extraction. Unlike the fully synthetic thymic bioregulators (Thymogen, Vladonix), Thymalin contains a mixture of naturally occurring thymic peptides including fractions with thymosin-like, thymopentin-like, and thymulin-like activities. It has been used clinically in Russia and Eastern Europe for immune deficiency states and is one of the most extensively clinically evaluated thymic preparations.
Thymic Involution and Aging
The thymus reaches peak activity in childhood and undergoes progressive involution from puberty onward, losing 3% of its functional tissue per year. By age 65, the thymus has lost approximately 95% of its T-cell generating capacity. This thymic involution is the primary driver of immunosenescence — the age-related decline in immune function increasing infection susceptibility, reducing vaccine efficacy, and possibly increasing cancer risk.
Research and Clinical Applications
Thymalin has been studied and used clinically for secondary immunodeficiency (post-chemotherapy, post-infection), primary immunodeficiency states, recurrent infections in the elderly, and anti-aging protocols. Long-term studies by Khavinson's group in elderly subjects documented reduced cancer incidence, improved immune parameters, and lower cardiovascular mortality over 6–8 year follow-up periods in subjects receiving periodic bioregulator courses including Thymalin.
Quick Reference
| Literature-Reported Dose Range | 5-20 mg per IM injection (Russian label) |
| Literature-Reported Frequency | Once daily for 3-10 days |
| Literature-Reported Cycle Length | 3-10 days per course |
| Literature-Reported Washout | Every 3-6 months, or annual cycles |
| Storage | Lyophilized: 2-8°C. Reconstituted: use immediately, do not store |
| Sites Reported in Studies | IM: deltoid, vastus lateralis, or gluteal |
| Timing | Daily IM during the course |
Research Indications
Immunity
Age-Related Immune Decline
Russian label indication and basis of the 6-8 year geroprotective trial.
T-Cell Maturation
Increases CD28+ mature T-cell populations from CD117+ progenitors in vitro.
Inflammation
Cytokine Suppression
Reduces TNF-alpha, IL-6, IL-1beta in PBMCs and in COVID-19 RCT patients.
Anti-Aging
Geroprotection
Annual cycles in elderly reported to reduce all-cause mortality in long-term observational data (interpret cautiously).
Recovery
Post-Chemo/Radiotherapy Immune Recovery
Approved Russian indication during and after oncology treatment.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Russian Label (Adult) | 5-20 mg | Once daily for 3-10 days | IM |
| COVID-19 RCT | 10 mg | Once daily for 10 days | IM |
Timing
Recommended administration window: daily IM during the course. Typical onset: lymphocyte shifts within 7-10 days in clinical data; geroprotective effects assessed over years.
Peptide Interactions
Thymalin and Thymulin are frequently confused but are different compounds. Thymulin is a single 9-amino-acid zinc-dependent metallopeptide (FTS). Thymalin is a multi-peptide thymic extract containing EW, KE, EDP and other fragments. They share the thymic bioregulator class but have different mechanisms and dosing. Verify the product label before use.
The original Khavinson geroprotective protocols pair Thymalin (thymic axis) with Epitalon or Epithalamin (pineal axis). The 6-8 year longevity trial in elderly subjects used annual courses of both, and reported larger mortality reductions for the combination than for either alone.
Both target thymic-axis immunity but via different mechanisms. Thymosin Alpha-1 is a single synthetic 28-amino-acid peptide acting on TLR signaling. Thymalin is a multi-peptide extract acting partly via epigenetic regulation through KE and EW dipeptide constituents. No direct comparison studies, but mechanisms appear complementary.
Thymogen (Glu-Trp / EW dipeptide) is one of Thymalin's identified active constituents, now manufactured as a standalone synthetic peptide. Co-administration is redundant rather than synergistic: anyone using Thymalin is already receiving EW activity. Stacking risks unnecessary duplication of effect.
Both are Khavinson-developed bioregulators targeting different tissue axes (Pinealon = pineal/neuroprotective tripeptide; Thymalin = thymic/immune). Used together in Russian gerontology protocols. No published interaction data.
Chronic corticosteroid therapy suppresses thymic function. Thymalin's clinical rationale partly involves reversing this suppression. No formal interaction studies; theoretical interest as a steroid-sparing adjunct in autoimmune protocols, but no clinical data supports unsupervised co-use.
Thymalin's mechanism (accelerating T-cell maturation, increasing CD4+/CD28+ populations) is directionally opposite to post-transplant immunosuppression. Use in solid organ or bone marrow transplant recipients has not been studied and is theoretically contraindicated.
Approved indication on the Russian label includes immune recovery after chemotherapy and radiotherapy. Cochrane class-level review of thymic peptides in cancer (PMID 21328265, not Thymalin-specific) showed reduced severe infection risk without survival benefit. Coordinate with the treating oncologist before combining.
Reported Research Timeline
01Day 1–3 (reported in cited studies): no immediately perceptible effects
02Day 7–10 (reported in cited studies): measurable immune marker shifts in clinical data
03Geroprotective use evaluated over annual cycles, not single courses
04Source quality matters: extract is more batch-dependent than synthetic peptides
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Russian label contraindications: hypersensitivity, pregnancy, lactation
Avoid in transplant immunosuppression (mechanism is directionally opposite)
Not formally studied in active autoimmune disease
Not FDA-approved or EMA-approved
Use during oncology should be coordinated with the treating oncologist
Seek Medical Attention If:
Hypersensitivity / allergic reaction
Injection site reaction beyond mild transient redness
Autoimmune flare in pre-existing autoimmune disease
Any unexpected systemic symptom
Quality Indicators
Verified Marker
White lyophilized powder, sealed vial
Legitimate Thymalin appears as white to off-white lyophilized powder in a sealed Samson-Med vial with batch and expiry.
Verified Marker
Clear reconstituted solution
Should be completely clear after reconstitution with 0.9% saline.
Verified Marker
Refrigerated cold chain
Vials require 2-8°C storage and shipping with cold packs.
Acceptable Range
Verify product is Thymalin, not Thymulin
Vendors occasionally mislabel. Confirm vial label and COA specify Thymalin (polypeptide complex).
Quality Concern
Cloudy, yellow, or particulate solution
Indicates degradation or contamination. Discard.
Research Citations
- Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19
Khavinson VKh, Kuznik BI, Trofimova SV, Lukyanov SA, Rutkovskaya VN, 2021, Stem Cell Reviews and Reports - The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity
Khavinson VKh, Linkova NS, Chalisova NI, Ivko OM, 2021, Biology Bulletin Reviews - Peptides of pineal gland and thymus prolong human life
Khavinson VKh, Morozov VG, 2003, Neuroendocrinology Letters - Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
Khavinson VK, Linkova NS, Kvetnoy IM, et al., 2020, Bulletin of Experimental Biology and Medicine - The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
Linkova N, Khavinson V, Diatlova A, et al., 2023, International Journal of Molecular Sciences - Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
Avolio F, Martinotti S, Khavinson VK, et al., 2022, International Journal of Molecular Sciences - Thymic peptides for treatment of cancer patients
Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M, 2011, Cochrane Database of Systematic Reviews - Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
Avolio F, Martinotti S, Khavinson VK, 2022, Int J Mol Sci - Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
Khavinson VK, Linkova NS, Kvetnoy IM, 2020, Bull Exp Biol Med - [Geroprotective effect of thymalin and epithalamin]
Khavinson VKh, Morozov VG, 2002, Adv Gerontol - The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
Linkova N, Khavinson V, Diatlova A, 2023, Int J Mol Sci - [Influence of peptides from pineal gland on thymus function at aging]
Lin'kova NS, Poliakova VO, Trofimov AV, 2010, Adv Gerontol
Research Focus
Immune restoration, Thymus support, Anti-aging, T-cell function, Longevity
Verified Vendors Carrying Thymalin
Frequently Asked Questions
What should researchers watch for with Thymalin?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Thymalin?
Day 1–3 (reported in cited studies): no immediately perceptible effects
How is Thymalin typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →